An Evolved Approach to Advisory Boards in Rare Disease Drug Development: 5-Step Model to Finding and Engaging Patient Advisors

Nearly all new product development teams at pharmaceutical companies will routinely conduct patient advisory boards. These board meetings will help collect and document the experience of patients and caregivers for medical product development and regulatory decision-making. Recently, in June 2020, T...

Descripción completa

Detalles Bibliográficos
Autores principales: Dillon, Carlotta, Knapp, Joyce, Stinson, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786749/
https://www.ncbi.nlm.nih.gov/pubmed/33457532
http://dx.doi.org/10.1177/2374373520948441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786749/
https://www.ncbi.nlm.nih.gov/pubmed/33457532
http://dx.doi.org/10.1177/2374373520948441

Ejemplares similares